AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

BORTEZOMIB

38 registrations across 6 African markets— 34 active

Markets with BORTEZOMIB

🇿🇦South Africa
20 registrations
20 active
🇬🇭Ghana
5 registrations
4 active
🇰🇪Kenya
5 registrations
5 active
🇹🇳Tunisia
3 registrations
0 active
🇿🇼Zimbabwe
3 registrations
3 active
🇺🇬Uganda
2 registrations
2 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
BORTERO
Injection
🇰🇪KenyaHetero Labs LimitedactiveMay 2030
Bortezomib for Injection; 3.5 mg/vial
Injection
🇰🇪KenyaDR. REDDY’S LABORATORIES LIMITEDactiveDec 2029
BORTEZOMIB 3,5 mg EUROLAB🇿🇦South AfricaEurolab (Pty) LtdactiveOct 2029
BERTRED 3,5🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveSept 2029
BORTEZOMIB ZYDUS🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveSept 2029
ZYMIB🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveSept 2029
MIBZO
POWDER/INJECTABLE; INJECTION
🇿🇼ZimbabweMSN LABORATORIES LTDactiveAug 2029
BETANUZ🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJun 2028
DEVACAD🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJun 2028
PROTECADE 1 mg🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveJun 2028
PROTECADE 3,5 mg🇿🇦South AfricaAdcock Ingram Critical Care (Pty) LtdactiveJun 2028
BORTEZOMIB POWDER INJECTION🇬🇭Ghana—activeJun 2028
BORTEZOMIB POWDER INJECTION🇬🇭Ghana—activeJun 2028
BORTEZOMIB EQUITY🇿🇦South AfricaEquity Pharmaceutical (Pty) LtdactiveApr 2028
MYZOMIB
POWDER/INJECTABLE; INJECTION
🇿🇼ZimbabweMYLAN LAB LTDactiveDec 2027
BORTERO
POWDER/INJECTABLE; INJECTION
🇿🇼ZimbabweHETERO LABS LTDactiveDec 2027
VALTIB 3,5 SOLUTION FOR INJECTION🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveNov 2027
VALTIB 2,5 SOLUTION FOR INJECTION🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveNov 2027
NEOMIB-2mg
Injection
🇰🇪KenyaGETWELL PHARMACEUTICALS LTDactiveAug 2027
BORTEBIN
Powder And Solution For Solution For Injectio
🇰🇪KenyaAUROBINDO PHARMA LIMITEDactiveJan 2027
BORTERO INJECTION (Each vial contains: Bortezomib 3.5mg)🇬🇭Ghana—expiredOct 2026
BORTERO INJECTION (Each vial contains: Bortezomib 3.5mg)🇬🇭Ghana—activeOct 2026
BORTERO INJECTION (Each vial contains: Bortezomib 3.5mg)🇬🇭Ghana—activeOct 2026
NEOMIB-3.5mg
Powder For Injection
🇰🇪KenyaGETWELL PHARMACEUTICALS LTDactiveJul 2026
MIBLEX🇿🇦South AfricaEurolab (Pty) LtdactiveJun 2023
VEELBORE
Poudre pour solution injectable / 3.5mg
🇹🇳TunisiaHIKMA PharmaceuticalsexpiredSept 2021
BORTEZOMIB NEAPOLIS
Pdre p.prep.injectable / 3.5 mg
🇹🇳TunisiaNEAPOLIS PHARMAexpiredFeb 2019
VELCADE
Pdre p.prep.injectable / 3.5 mg
🇹🇳TunisiaJanssen-Cilag International N.VexpiredAug 2015
BERTRED 1🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJan 1900
VALOMA 2,5🇿🇦South AfricaJuno Pharma SA (Pty) LtdactiveJan 1900
VALOMA 3,5🇿🇦South AfricaJuno Pharma SA (Pty) LtdactiveJan 1900
BORTRAC 3,5 mg🇿🇦South AfricaActivo Health (Pty) LtdactiveJan 1900
VELCADE🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJan 1900
BORTEZOMIB HETERO 3,5 mg🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveJan 1900
VALOMA 1🇿🇦South AfricaJuno Pharma SA (Pty) LtdactiveJan 1900
VELCADE 1 mg🇿🇦South AfricaJanssen Pharmaceutica (Pty) LtdactiveJan 1900
BORTEZOMIB
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaAUROBINDO PHARMA LIMITEDactive—
BORTEZOMIB
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaAUROBINDO PHARMA LIMITEDactive—

BORTEZOMIB in Africa — Regulatory Overview

BORTEZOMIB is registered across 6 African markets with 38 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Kenya, Tunisia and 2 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 38 registrations, 34 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.